Inovio Pharmaceuticals Company
Inovio is a biotech company focusing on bringing to market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.
Technology:
DNA
Industry:
DNA
Headquarters:
Plymouth Meeting, Pennsylvania, United States
Founded Date:
1979-01-01
Employees Number:
251-500
Funding Status:
IPO
Investors Number:
6
Total Funding:
64900000
Estimated Revenue:
$50M to $100M
Last Funding Date:
2021-01-20
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership